In our research, we found that cleavage of CAD in GC and CRC cells by caspase-3 at the Asp1371 site leads to inhibition of de novo pyrimidine synthesis, which is crucial for their death when treated with different chemotherapeutic drugs. Here, CASP3 is linked to gastric cancer.